
Cefavial TZ 250mg/31.25mg Injection
Marketer
Werke Healthcare
Salt Composition
Ceftriaxone (250mg) + Tazobactum (31.25mg)
Overview Cefavial TZ 250mg/31.25mg Injection
Cefavial TZ 250mg/31.25mg injection, a dual-action antibiotic, combats diverse bacterial infections. Its mechanism halts microbial proliferation, thereby containing infection spread. Administration must always be under a doctor's guidance; adhere strictly to the prescribed schedule. Complete the full course, regardless of symptom improvement; premature cessation may compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Severe side effects necessitate immediate medical attention. Allergic reactions (skin rashes, itching, edema, respiratory distress) require emergency care. Inform your physician of all current medications, particularly if pregnant or breastfeeding, before commencing treatment. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing to driving ability, refrain from driving if experiencing dizziness or somnolence. Adequate rest, a balanced diet, and sufficient hydration promote faster recovery. Your doctor may order tests to monitor treatment response.
Primary Ingredients of Cefavial TZ 250mg/31.25mg Injection
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Cefavial TZ 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Cefavial TZ 250mg/31.25mg Injection:
The medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Cefavial TZ 250mg/31.25mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Cefavial TZ 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Cefavial TZ 250mg/31.25mg Injection works:
Ceftriaxone and Tazobactum, combined as Cefavial TZ 250mg/31.25mg Injection, offer a targeted antibacterial approach. Ceftriaxone, a third-generation cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering their growth and survival. Tazobactum, a beta-lactamase inhibitor, complements Ceftriaxone by neutralizing bacterial enzymes that would otherwise break down the antibiotic, thus bolstering its effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concomitant use of alcohol and Cefavial TZ 250mg/31.25mg Injection.
PregnancySAFE IF PRESCRIBED
Pregnancy use of Cefavial TZ 250mg/31.25mg Injection is typically regarded as safe. Preclinical trials in animals revealed minimal or absent harm to offspring; nonetheless, data from human trials are scarce.
Breast feedingCAUTION
The administration of Cefavial TZ 250mg/31.25mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily suspended throughout the mother's course of treatment and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Cefavial TZ 250mg/31.25mg Injection might induce drowsiness, blurred vision, or dizziness. Driving is contraindicated if such effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Cefavial TZ 250mg/31.25mg Injection to individuals with renal impairment. Physician consultation is recommended.
LiverCAUTION
The injectable medication Cefavial TZ 250mg/31.25mg requires careful administration in individuals with significant hepatic impairment; dosage modification may be necessary. Consult a physician for guidance. Dosage alteration for Cefavial TZ 250mg/31.25mg Injection is not advised for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Cefavial TZ 250mg/31.25mg Injection :
Omit a Cefavial TZ 250mg/31.25mg Injection dose? Seek medical advice immediately.
Facts to Know About Cefavial TZ 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-infective agents |
